Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
iST Jobst, formerly Jobst Technologies GmbH, is a Germany-based biosensor and microfluidics company focused on electrochemical analytics, analyte monitoring, and custom microsystems solutions for biotechnology, pharmaceutical, medical, and diagnostics applications. Founded in 2002 as a spin-off from the University of Freiburg's IMTEK, the company develops and manufactures chemical sensors for methanol, ethanol, and oxygen, as well as biosensors for glucose, lactate, glutamine, and glutamate. Its offerings also include microfluidic systems, sensor arrays, robotic dispensing systems, and integrated monitoring solutions that combine sensors, electronics, software, and fluidics. The company operates as an acquired subsidiary of Innovative Sensor Technology IST AG and was rebranded to iST Jobst in November 2025. Rather than a therapeutic drug developer, it is best understood as a commercial platform and components supplier serving bioprocessing, medical technology, and life science instrumentation markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on iST Jobst.